Cwm LLC Raises Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

Cwm LLC lifted its holdings in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 255.3% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,022 shares of the company’s stock after buying an additional 12,950 shares during the period. Cwm LLC’s holdings in Bath & Body Works were worth $575,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of BBWI. First Community Trust NA purchased a new position in Bath & Body Works in the 2nd quarter valued at approximately $30,000. GAMMA Investing LLC grew its holdings in Bath & Body Works by 75.7% during the 1st quarter. GAMMA Investing LLC now owns 1,116 shares of the company’s stock valued at $56,000 after buying an additional 481 shares during the last quarter. EntryPoint Capital LLC grew its holdings in Bath & Body Works by 224.0% during the 1st quarter. EntryPoint Capital LLC now owns 1,471 shares of the company’s stock valued at $74,000 after buying an additional 1,017 shares during the last quarter. First Financial Corp IN grew its holdings in Bath & Body Works by 30.0% during the 1st quarter. First Financial Corp IN now owns 2,571 shares of the company’s stock valued at $129,000 after buying an additional 594 shares during the last quarter. Finally, Blue Trust Inc. grew its holdings in Bath & Body Works by 23.4% during the 2nd quarter. Blue Trust Inc. now owns 2,767 shares of the company’s stock valued at $108,000 after buying an additional 524 shares during the last quarter. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Price Performance

Shares of BBWI opened at $31.94 on Friday. The stock’s 50-day moving average is $30.92 and its two-hundred day moving average is $38.50. The stock has a market cap of $7.13 billion, a PE ratio of 8.23, a P/E/G ratio of 0.94 and a beta of 1.77. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The company had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.54 billion. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.18 earnings per share for the current year.

Bath & Body Works Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, September 6th. Investors of record on Friday, August 23rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 2.50%. The ex-dividend date of this dividend was Friday, August 23rd. Bath & Body Works’s dividend payout ratio (DPR) is 20.62%.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of analyst reports. UBS Group lowered their target price on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. The Goldman Sachs Group lowered their target price on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Evercore ISI decreased their price objective on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating on the stock in a report on Wednesday, August 28th. Telsey Advisory Group restated an “outperform” rating and set a $42.00 price objective on shares of Bath & Body Works in a report on Thursday, September 26th. Finally, Barclays decreased their price objective on Bath & Body Works from $32.00 to $31.00 and set an “equal weight” rating on the stock in a report on Thursday, August 29th. Eight equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $42.35.

Insider Buying and Selling

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The shares were acquired at an average price of $29.64 per share, for a total transaction of $177,840.00. Following the completion of the purchase, the chief executive officer now owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 0.00 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.27% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.